UK Hepatitis Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2508

  • Format: PPT, PDF

UK Hepatitis Therapeutics Market: Segmented by Disease type (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E), Drug class (Interferon, Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Nucleotide Analog, Reverse Transcriptase Inhibitors, Nucleotide Analog NS5B Polymerase Inhibitors, Multi Class Combination) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 2508 Categories: ,

Report Overview

The UK hepatitis therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Hepatitis is an inflammation, or swelling, of the liver. Hepatitis may occur due to drugs, alcohol use, or certain medical conditions. But in most of the cases, it is caused by a virus called viral hepatitis, and the most common forms are hepatitis A, B, and C. Hepatitis is a very common disease and can lead to serious scarring (cirrhosis) of the liver and liver failure, which can be fatal. It is estimated that 113,000 people in England are living with chronic hepatitis C.

Some of the common symptoms of hepatitis are loss of appetite, nausea and vomiting, fatigue, fever, body aches, and stomach pain. Some people may experience light-coloured bowel movements, dark urine, and yellowing of the skin or of the eyes (jaundice). Viral infections of the liver are classified as hepatitis A, B, C, D, and E. A different virus is responsible for each type of virally transmitted hepatitis. Hepatitis A is an acute, short-term disease, while hepatitis B, C, and D are mostly ongoing and chronic. Hepatitis E is usually acute but can be particularly dangerous in pregnant women. Hepatitis can be diagnosed through history and physical exam, liver function tests, blood tests, and ultrasound. Some of the complications of hepatitis B or C are chronic liver disease, cirrhosis, and liver cancer. In UK, Hepatitis B and C affect millions of people.

Market Drivers

An increase in the prevalence of viral hepatitis, promising pipeline of hepatitis drugs, and supportive government initiatives encouraging patients in the adoption of hepatitis drugs are the key driving factors in the UK’s hepatitis therapeutics market. The introduction of generic versions of HCV drugs has changed the market dynamics across the world. With more people being able to afford the generic versions, the usage rates of its drugs are expected to grow rapidly over the next few year and as the accessibility of these drugs is a major issue among the low-income group, the generic cases are a saviour when it comes to the treatment of hepatitis in UK.


Potential causes.

Almost 90% of hepatitis C cases in the UK occur in people who inject drugs or have injected them in the past. It is estimated around half of the people in the UK who inject drugs have the infection.


Infectious causes are further subdivided into viral, parasitic, and bacterial among which viral is the most common one.


Auto immune causes are further subdivided into Alcoholic, Toxic and drug induced as well as Non- alcoholic fatty lever disease.

Auto immune

It is a chronic disease caused by abnormal immune response against lever cells.


Genetic causes of hepatitis include alpha-1-antitrypsin deficiency, hemochromatosis, and Wilson’s disease and are hereditary.

Ischemic hepatitis

It is characterized by reduced blood flow to lever because of shocks, vascular inefficiency or heat failure.

1. UK Hepatitis therapeutics Market Overview…………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Increasing prevalence of hepatitis cases
B. Induction of generic hepatitis drugs
C. Government attention and initiatives
3. Potential causes of Hepatitis diseases………………………………………………..
A. Infectious
B. Auto immune
C. Metabolic
D. Genetic
E. Ischemic hepatitis
4. Hepatitis therapeutics Market Segmentation……………………………………………
A. Disease type
I. Hepatitis A
II. Hepatitis B
III. Hepatitis C
IV. Hepatitis D
V. Hepatitis E
B. Drug class
I. Interferon monoclonal antibody
II. Non-structural protein inhibitors
III. Nucleotide Analog
IV. Reverse transcriptase inhibitors
V. Nucleotide analog polymerase inhibitors
VI. Multi class Combination
5. Hepatitis drugs Major Products Market Share………………………………
A. Key Findings
B. Market Analysis, Insights and Forecast
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. GSK Company overview, Product & Services, Strategies & Financials
B. Merck Sharp Company overview, Product & Services, Strategies & Financials
C. Gilead sciences Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Hepatitis drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By disease type:

Based on the disease type the hepatitis market in UK is segmented into Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D & Hepatitis E. UK is differentiated from the world when the segmentation is done based on disease type. While the global prevalence of Hepatitis C is high, in UK hepatitis B is more frequent and is expected to register a market share of USD xx billion in 2024.

By Drug class:

Based on the drug class, the hepatitis market in UK is segmented into Interferon Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Nucleotide Analog, Reverse Transcriptase Inhibitors, Nucleotide Analog NS5B Polymerase Inhibitors, Multi Class Combination.

Top 5 Major Players

The UK’s Hepatitis Therapeutics Market is fragmented competitive and consists of several major players. However, in terms of market share, few of the major players are currently dominating the market. Some of the leading market players include Merck & Co., Inc, Gilead Sciences, Inc, AbbVie Inc, Bristol Myers Squibb Company, F. Hoffmann-La Roche, Ltd, LAURUS Labs, Zydus Cadila, Hetero Healthcare Limited, NATCO Pharma Limited and Cipla, Inc.

NHS England has reached agreement with three drug companies to supply drugs to eliminate hepatitis C. The procurement, said to be the largest ever negotiated by the NHS, was complex because it set out to acquire treatments on the best possible terms for the NHS while avoiding the “winner takes all” approach based simply on price. The aim was to provide certainty so that the companies could plan several years ahead. NHS England also wanted the companies to help find patients, many of whom might not even realise they carry hepatitis C. More than two thirds of the estimated 160 000 people infected with the virus do not currently have a diagnosis. A further complication was that of the three companies—Gilead Sciences, Merck Sharp and Dohme (MSD) and AbbVie.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements